Revolutionary Urine Test Offers Early Lung Cancer Detection

Scientists at the University of Cambridge and Early Cancer Institute have developed a pioneering urine test that could detect early signs of lung cancer by identifying proteins from "zombie" cells, which are damaged cells that promote cancer development. This test, which has been successful in mice and is set for human trials, uses an injectable sensor to release a detectable compound into urine, potentially allowing for earlier and more affordable cancer detection compared to traditional scans. Lung cancer is the leading cause of cancer deaths globally, making early detection crucial for improving survival rates.